May 15 |
Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'
|
May 14 |
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
|
May 14 |
Danish biotech says companies should tap into China’s ‘impressive innovation’
|
May 3 |
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
|
May 2 |
Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
|
May 2 |
Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
|
May 2 |
Genmab reports Q1 results
|
May 2 |
Genmab Announces Financial Results for the First Quarter of 2024
|
May 1 |
Genmab Q1 2024 Earnings Preview
|
May 1 |
Genmab: A Complicated Tale
|